NEBULA
Vandoeuvre-lès-nancy
About NEBULA
NEBULA maps 3D macromolecule using dataset-free genAI and physics, enhancing drug target discovery, which forms the basis of all new drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $137.1K
- Last round: Grant (Dec 2024)
- Website: nebulabio.tech
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Bioinformatics, Biopharma, Biotechnology, Generative AI
Social Profiles
Canonical: https://fsome.com/organization/nebula-58795 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.